Oligometastic progression (or solitary metastases) can justify ablative treatment for metastatic treatment. When such a strategy is discussed, it is important to notice that definition of oligometastases is not consensual both in terms of clinical presentation than on the biological basis. Does a specific biological background truly exist and are there markers that could predict for additional occult disease and its oligo or polymetastatic profile in individuals with demonstrated oligometastasis. This article provides a summary of the state of the art in this field and highlights some current areas of controversies.
Keywords: Chirurgie des métastases; Metastasectomy; Oligometastasis; Oligométastase; Oligoprogression; Radiothérapie; Stereotactic radiotherapy; stéréotaxique.
© 2016 Société Française du Cancer. Publié par Elsevier Masson SAS.